Bide Pharmaceutical Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 734

Employees

  • Stock Symbol
  • 688073

Stock Symbol

  • Share Price
  • $9.58
  • (As of Friday Closing)

Bide Pharmaceutical General Information

Description

Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Room 101, Block A, Building 1
  • No. 128 Xiangyin Road, Yangpu District
  • Shanghai, 200433
  • China
+86 021
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Corporate Office
  • Room 101, Block A, Building 1
  • No. 128 Xiangyin Road, Yangpu District
  • Shanghai, 200433
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bide Pharmaceutical Stock Performance

As of 13-Nov-2026, Bide Pharmaceutical’s stock price is $9.58. Its current market cap is $870M with 90.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.58 $10.08 $6.38 - $13.18 $870M 90.9M 4.94M $0.33

Bide Pharmaceutical Financials Summary

As of 30-Sep-2026, Bide Pharmaceutical has a trailing 12-month revenue of $203M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 906,357 662,509 465,655 549,362
Revenue 202,528 184,085 153,580 154,329
EBITDA 33,953 30,625 22,005 18,018
Net Income 28,427 21,100 16,365 15,487
Total Assets 384,955 359,712 331,233 340,692
Total Debt 19,415 20,163 11,260 8,083
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bide Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bide Pharmaceutical‘s full profile, request access.

Request a free trial

Bide Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Bide Pharmaceutical‘s full profile, request access.

Request a free trial

Bide Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bide Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Bide Pharmaceutical’s complete esg history, request access »

Bide Pharmaceutical FAQs

  • When was Bide Pharmaceutical founded?

    Bide Pharmaceutical was founded in 2007.

  • Where is Bide Pharmaceutical headquartered?

    Bide Pharmaceutical is headquartered in Shanghai, China.

  • What is the size of Bide Pharmaceutical?

    Bide Pharmaceutical has 734 total employees.

  • What industry is Bide Pharmaceutical in?

    Bide Pharmaceutical’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Bide Pharmaceutical a private or public company?

    Bide Pharmaceutical is a Public company.

  • What is Bide Pharmaceutical’s stock symbol?

    The ticker symbol for Bide Pharmaceutical is 688073.

  • What is the current stock price of Bide Pharmaceutical?

    As of 13-Nov-2026 the stock price of Bide Pharmaceutical is $9.58.

  • What is the current market cap of Bide Pharmaceutical?

    The current market capitalization of Bide Pharmaceutical is $870M.

  • What is Bide Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Bide Pharmaceutical is $203M.

  • What is Bide Pharmaceutical’s annual earnings per share (EPS)?

    Bide Pharmaceutical’s EPS for 12 months was $0.33.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process